BioSpace News Archive

Metabolon, the world leader in metabolomics, today announced that Dr. Jan Lundberg, Ph.D. has joined its Board of Directors.

Canopy Growth Corporation filed its Amended and Restated Management Discussion and Analysis for the three and nine months ended December 31, 2018 to correct the Adjusted EBITDA1 in the original MD&A for the nine months ended December 31, 2018 filed on February 14, 2019, as follows.

Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has been awarded a group purchasing agreement for SURPASS with Premier.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company” or “we”) today announced its fourth-quarter and full-year 2018 financial results.

AVEO Oncology (NASDAQ:AVEO) today announced that Michael Bailey, president and chief executive officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 2:30 p.m. Eastern Time.

BiomX Ltd., a microbiome company developing customized phage therapies, today announced the closing of a $32 million series B equity financing.

New point-of-care rapid test identifies and helps make effective care more accessible for millions of people living with hepatitis B, in support of World Health Organization (WHO) hepatitis targets

Orangetheory Fitness has been named to Fast Company’s prestigious annual list of the World’s 50 Most Innovative Companies for 2019.

Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead nanoparticle formulation for the detection of HER2 metastatic breast cancer.

Inovio Pharmaceuticals, Inc. in collaboration with The Wistar Institute and the University of Pennsylvania announced that the first subject was dosed as part of the first-ever human study of Inovio’s DNA-encoded monoclonal antibody technology.